These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 16239591

  • 1. HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ, Happé H, Hauer AD, de Vos P, Imanishi T, Fujiwara H, van Berkel TJ, Kuiper J.
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2642-7. PubMed ID: 16239591
    [Abstract] [Full Text] [Related]

  • 2. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
    Tokuyama H, Ueha S, Kurachi M, Matsushima K, Moriyasu F, Blumberg RS, Kakimi K.
    Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
    [Abstract] [Full Text] [Related]

  • 3. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y, Yu WG, Mukai T, Gao P, Yamaguchi N, Murai M, Matsushima K, Obika S, Imanishi T, Higashibata Y, Nomura S, Kitamura Y, Fujiwara H, Hamaoka T.
    Cancer Res; 2002 Jul 01; 62(13):3751-8. PubMed ID: 12097285
    [Abstract] [Full Text] [Related]

  • 4. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
    Baba M, Takashima K, Miyake H, Kanzaki N, Teshima K, Wang X, Shiraishi M, Iizawa Y.
    Antimicrob Agents Chemother; 2005 Nov 01; 49(11):4584-91. PubMed ID: 16251299
    [Abstract] [Full Text] [Related]

  • 5. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice.
    van Wanrooij EJ, de Jager SC, van Es T, de Vos P, Birch HL, Owen DA, Watson RJ, Biessen EA, Chapman GA, van Berkel TJ, Kuiper J.
    Arterioscler Thromb Vasc Biol; 2008 Feb 01; 28(2):251-7. PubMed ID: 18048768
    [Abstract] [Full Text] [Related]

  • 6. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA.
    Circulation; 2007 Jan 30; 115(4):501-8. PubMed ID: 17242282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of blocking the chemokine receptors, CCR5 and CXCR3, With TAK-779 in a rat small intestinal transplantation model.
    Xu H, Firdawes S, Yamamoto A, Zhao Y, Ihara Y, Uehara S, Matsunami K, Otsuka H, Fukuzawa M, Miyagawa S.
    Transplantation; 2008 Dec 27; 86(12):1810-7. PubMed ID: 19104427
    [Abstract] [Full Text] [Related]

  • 9. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2006 Aug 27; 26(8):1858-63. PubMed ID: 16763157
    [Abstract] [Full Text] [Related]

  • 10. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.
    Takama Y, Miyagawa S, Yamamoto A, Firdawes S, Ueno T, Ihara Y, Kondo A, Matsunami K, Otsuka H, Fukuzawa M.
    Transpl Immunol; 2011 Jul 27; 25(1):49-55. PubMed ID: 21515370
    [Abstract] [Full Text] [Related]

  • 11. The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion.
    Tsutahara K, Okumi M, Kakuta Y, Abe T, Yazawa K, Miyagawa S, Matsunami K, Otsuka H, Kaimori J, Takahara S, Nonomura N.
    Nephrol Dial Transplant; 2012 Oct 27; 27(10):3799-806. PubMed ID: 22904101
    [Abstract] [Full Text] [Related]

  • 12. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
    Kakuta Y, Okumi M, Miyagawa S, Tsutahara K, Abe T, Yazawa K, Matsunami K, Otsuka H, Takahara S, Nonomura N.
    Transplantation; 2012 Jan 15; 93(1):24-31. PubMed ID: 22124337
    [Abstract] [Full Text] [Related]

  • 13. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.
    Kang SG, Piniecki RJ, Hogenesch H, Lim HW, Wiebke E, Braun SE, Matsumoto S, Kim CH.
    Gastroenterology; 2007 Mar 15; 132(3):966-81. PubMed ID: 17324406
    [Abstract] [Full Text] [Related]

  • 14. FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Zhao M, Wigren M, Dunér P, Kolbus D, Olofsson KE, Björkbacka H, Nilsson J, Fredrikson GN.
    J Immunol; 2010 Mar 01; 184(5):2253-60. PubMed ID: 20097865
    [Abstract] [Full Text] [Related]

  • 15. Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice.
    Kishi J, Nishioka Y, Kuwahara T, Kakiuchi S, Azuma M, Aono Y, Makino H, Kinoshita K, Kishi M, Batmunkh R, Uehara H, Izumi K, Sone S.
    Eur Respir J; 2011 Aug 01; 38(2):415-24. PubMed ID: 21273392
    [Abstract] [Full Text] [Related]

  • 16. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.
    Heredia A, Amoroso A, Davis C, Le N, Reardon E, Dominique JK, Klingebiel E, Gallo RC, Redfield RR.
    Proc Natl Acad Sci U S A; 2003 Sep 02; 100(18):10411-6. PubMed ID: 12915736
    [Abstract] [Full Text] [Related]

  • 17. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
    Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F.
    Circ Res; 2004 Feb 06; 94(2):253-61. PubMed ID: 14656931
    [Abstract] [Full Text] [Related]

  • 18. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S, Gijbels MJ, van der Made I, Mujcic H, Thelen M, Vergouwe MN, Ambagts MH, Hofker MH, de Winther MP.
    Cardiovasc Res; 2008 Nov 01; 80(2):309-18. PubMed ID: 18628255
    [Abstract] [Full Text] [Related]

  • 19. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
    Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE.
    Circulation; 2006 May 16; 113(19):2301-12. PubMed ID: 16682613
    [Abstract] [Full Text] [Related]

  • 20. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.
    Thorp E, Kuriakose G, Shah YM, Gonzalez FJ, Tabas I.
    Circulation; 2007 Nov 06; 116(19):2182-90. PubMed ID: 17967777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.